Literature DB >> 11295495

Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.

A Ciechanover1, H Gonen, B Bercovich, S Cohen, I Fajerman, A Israël, F Mercurio, C Kahana, A L Schwartz, K Iwai, A Orian.   

Abstract

In most cases, target proteins of the ubiquitin system are completely degraded. In several exceptions, such as the first step in the activation of the transcriptional regulator NF-kappaB, the substrate, the precursor protein p105, is processed in a limited manner to yield the active subunit p50. p50 is derived from the N-terminal domain of p105, whereas the C-terminal domain is degraded. The mechanisms involved in this unique process have remained elusive. We have shown that a Gly-rich region (GRR) at the C-terminal domain of p50 is one important processing signal and that it interferes with processing of the ubiquitinated precursor by the 26S proteasome. Also, amino acid residues 441-454 are important for processing under non-stimulated conditions. Lys 441 and 442 serve as ubiquitination targets, whereas residues 446-454 may serve as a ligase recognition motif. Following IkappaB kinase (IKK)-mediated phosphorylation, the C-terminal domain of p105, residues 918-934, recruits the SCF(beta-TrCP) ubiquitin ligase, and ubiquitination by this complex leads to accelerated processing. The two sites appear to be recognized under different physiological conditions by two different ligases, targeting two distinct recognition motifs. We have shown that ubiquitin conjugation and processing of a series of precursors of p105 that lack the C-terminal IKK phosphorylation/TrCP binding domain, is progressively inhibited with increasing number of ankyrin repeats. Inhibition is due to docking of active NF-kappaB subunits to the ankyrin repeat domain in the C-terminal half of p105 (IkappaBgamma). Inhibition is alleviated by phosphorylation of the C-terminal domain that leads to ubiquitin-mediated degradation of the ankyrin repeat domain and release of the anchored subunits. We propose a model that may explain the requirement for two sites: a) a basal site that may be involved in co-translational processing prior to the synthesis of the ankyrin repeat domain; and b) a signal-induced site that is involved in processing/degradation of the complete molecule following cell activation, with rapid release of stored, transcriptionally active subunits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295495     DOI: 10.1016/s0300-9084(01)01239-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  19 in total

1.  PI31 is a modulator of proteasome formation and antigen processing.

Authors:  Dietmar M W Zaiss; Sybille Standera; Peter-M Kloetzel; Alice J A M Sijts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

2.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 3.  Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 4.  Ubiquitin signalling in the NF-kappaB pathway.

Authors:  Zhijian J Chen
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

5.  Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP.

Authors:  Denis Tempé; Mariana Casas; Sonia Karaz; Marie-Françoise Blanchet-Tournier; Jean-Paul Concordet
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  Proteasomal degradation from internal sites favors partial proteolysis via remote domain stabilization.

Authors:  Daniel A Kraut; Andreas Matouschek
Journal:  ACS Chem Biol       Date:  2011-08-12       Impact factor: 5.100

7.  NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.

Authors:  Alejandra G Erlejman; Sonia A De Leo; Gisela I Mazaira; Alejandro M Molinari; María Fernanda Camisay; Vanina Fontana; Marc B Cox; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

Review 8.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

9.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 10.  Ubiquitin in NF-kappaB signaling.

Authors:  Yu-Hsin Chiu; Meng Zhao; Zhijian J Chen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.